The Allkem Ltd (ASX: AKE) share price has been a strong performer over the last 12 months.
As you can see below, the ASX lithium share has gained over 50% since this time last year.
Can this ASX lithium share keep rising?
According to a note out of Goldman Sachs, its analysts have been looking at the Australian lithium industry and believe Allkem is the only ASX lithium share to buy right now.
A note released this morning reveals that the broker has initiated coverage on Allkem with a buy rating and $15.20 price target.
Based on the current Allkem share price, this implies potential upside of 10% for investors.
What did the broker say?
As I covered here earlier, Goldman Sachs believes that lithium prices will start to decline materially during the second half of 2023.
It expects spodumene (6% grade) prices to go from an average of US$4,330 a tonne in 2023 to just US$800 a tonne in 2024. This is expected to be driven by lithium production growing larger than demand.
In light of this, the broker believes investors should be very selective when it comes to buying ASX lithium shares. It commented:
With the pricing backdrop, we prefer low cost producers with quality resources to underpin growth optionality and vertical integration over developers.
Based on this, Goldman believes that Allkem is the only ASX lithium share to buy right now. Particularly given its material production growth plans and attractive valuation. It adds:
With optionality across the Americas and Australia on the largest lithium resource in our coverage growing equity LCE production >4x by FY27E, and at a discount to peers at 1.02x NAV (peer average 1.3x), Allkem is our preferred lithium exposure. We initiate with a Buy rating and a 12-month PT of A$15.2/sh, implying 9% upside, where we see near-term Argentinian FX risk as overdone on the in-country reinvestment profile.
The post Goldman Sachs names the only ASX lithium share to buy today appeared first on The Motley Fool Australia.
FREE Beginners Investing Guide
Despite what some people may say – we believe investing in shares doesn’t have to be overwhelming or complicated…
For over a decade, we’ve been helping everyday Aussies get started on their journey.
And to help even more people cut through some of the confusion “experts’” seem to want to perpetuate – we’ve created a brand-new “how to” guide.
Yes, Claim my FREE copy!
*Returns as of November 7 2022
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- 5 things to watch on the ASX 200 on Thursday
- 10 ASX shares to buy in 2023
- Why are ASX 200 lithium shares taking a lashing today?
- Can ASX 200 lithium shares come charging back in December?
- Getting cold feet on ASX 200 lithium shares? Here’s why UBS ‘remains positive’
Motley Fool contributor James Mickleboro has positions in Allkem. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/wg4ZqFH
Leave a Reply